[EN] CHEMOSELECTIVE SENSITIVITY BOOSTER FOR TAGGING A PEPTIDE, PEPTIDE CONJUGATE, OR SIMILAR REACTIVE MOLECULE<br/>[FR] AMPLIFICATEUR DE SENSIBILITÉ CHIMIOSÉLECTIF POUR MARQUER UN PEPTIDE, UN CONJUGUÉ PEPTIDIQUE OU UNE MOLÉCULE RÉACTIVE SIMILAIRE
申请人:INDIAN INSTITUTE OF SCIENCE EDUCATION AND RES BHOPAL
公开号:WO2020245843A1
公开(公告)日:2020-12-10
The invention pertains to chemoselective sensitivity booster for tagging a peptide, peptide conjugate, or similar reactive molecule for analysis of a peptide, protein, antibody, protein bioconjugate, antibody bioconjugate, and similar analytes. The sensitivity booster comprises of sp2 or sp3 nitrogen centers in combination with hydrophobic carbon chains linked with an electrophile or nucleophile for attachment with a peptide, peptide conjugate, or molecules with similar reactivity.
N-Benzylation of primary amines using magnetic Fe3O4 nanoparticles functionalized with hexamethylenetetramine as an efficient and recyclable heterogeneous catalyst
Abstract Herein we report, a new, simple and mild procedure for N-benzylation and N,N-dibenzylation of anilines through the reaction of aniline derivatives and benzyl bromide at 60 °C in EtOH in the presence of catalytic amounts of magnetic Fe3O4 nanoparticles functionalized with hexamethylenetetramine (Fe3O4@SiO2@Propyl-HMTA). The title compounds were formed in high purity and their structures characterized
Synthesis, Crystal Structure, and Photoluminescence of Homodinuclear Lanthanide 4-(Dibenzylamino)benzoate Complexes
作者:A. R. Ramya、M. L. P. Reddy、Alan H. Cowley、Kalyan V. Vasudevan
DOI:10.1021/ic902257u
日期:2010.3.1
species that are bridged by two oxygen atoms from two carboxylate ligands via different coordination modes. The discrete bridged dimer of 1 is centrosymmetric and features 8-coordinate terbium atoms, each of which adopts a distorted square-antiprismatic geometry. Both coordination spheres comprise two η2-chelating benzoates, two μ-η1:η1-carboxylate interactions from the bridging benzoates, and two water
The present invention relates to a novel class of disubstituted aniline compounds. These compounds can inhibit hi-stone deacetylase and are suitable for use in selectively inducing terminal differentiation, and arresting cell growth and/or apoptosis of neoplastic cells, thereby inhibiting proliferation of such cells. Thus, the compounds of the present invention are useful in treating a patient having a tumor characterized by proliferation of neoplastic cells. The compounds of the invention may also be useful in the prevention and treatment of TRX-mediated diseases, such as autoimmune, allergic and inflammatory diseases, and in the prevention and/or treatment of diseases of the central nervous system (CNS), such as neurodegenerative diseases. The present invention further provides pharmaceutical compositions comprising the compounds of the instant invention and safe dosing regimens of these pharmaceutical compositions, which are easy to follow, and which result in a therapeutically effective amount of these compounds in vivo.